XML 77 R13.htm IDEA: XBRL DOCUMENT v3.19.3
Derivative Instruments
 9 Months Ended
Sep. 28, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Instruments Derivative Instruments
Foreign Currency Exchange Forward Contracts
The Company transacts business in various foreign currencies and has international sales, cost of sales, and expenses denominated in foreign currencies, and carries foreign-currency-denominated monetary assets and liabilities, subjecting the Company to foreign currency risk. The Company’s primary foreign currency risk management objective is to protect the U.S. dollar value of future cash flows and minimize the volatility of reported earnings. The Company utilizes foreign currency exchange forward contracts, primarily short term in nature.
The Company periodically enters into foreign currency exchange forward contracts to manage its exposure to fluctuation in foreign exchange rates that arise from its euro and British pound denominated receivables and restricted cash balances. Gains and losses on these contracts are intended to offset the impact of foreign exchange rate fluctuations on the underlying foreign currency denominated accounts receivables and restricted cash, and therefore, do not subject the Company to material balance sheet risk.
The Company also enters into foreign currency exchange forward contracts to reduce the volatility of cash flows primarily related to forecasted revenue and expenses denominated in euros, British pounds and Swedish kronors (“SEK”). The contracts are settled at maturity and at rates agreed to at inception of the contracts. The gains and losses on these foreign currency derivatives are recorded to the consolidated statement of operations line item, in the current period, to which the item that is being economically hedged is recorded.
For the three months ended September 28, 2019 and September 29, 2018, the before-tax effect of the foreign currency exchange forward contracts was a net gain of $0.5 million and $0.1 million, respectively, and for the nine months ended September 28, 2019 and September 29, 2018, the before-tax effect of the foreign currency exchange forward contracts was a net gain of $1.2 million and $0.6 million, respectively. In each of these periods, the impact of the gross gains and losses was offset by foreign exchange rate fluctuations on the underlying foreign currency denominated amounts.
As of September 28, 2019, the Company did not designate foreign currency exchange forward contracts as hedges for accounting purposes and accordingly, changes in the fair value are recorded in the accompanying condensed consolidated statements of operations. These contracts were entered into with one high-quality institution and the Company consistently monitors the creditworthiness of the counterparties.
The fair value of derivative instruments not designated as hedging instruments in the Company’s condensed consolidated balance sheets was as follows (in thousands):
 
As of September 28, 2019
 
As of December 29, 2018
 
Gross Notional(1)  
 
Other Accrued Liabilities
 
Gross Notional(1)  
 
Other Accrued Liabilities
Foreign currency exchange forward contracts
 
 
 
 
 
 
 
Related to euro denominated receivables
$
30,527

 
$
(102
)
 
$
40,068

 
$
(52
)
Related to British pound denominated receivables
$
—

 
—

 
$
6,412

 
(38
)
Related to euro denominated restricted cash
$
—

 
—

 
$
240

 
(1
)
 


 
$
(102
)
 


 
$
(91
)
(1) 
Represents the face amounts of forward contracts that were outstanding as of the end of the period noted.
Accounts Receivable Factoring
The Company has sold certain designated trade account receivables based on factoring arrangements to a large international banking institution. Pursuant to the terms of the arrangements, the Company accounts for these transactions in accordance with ASC 860, “Transfers and Servicing.” The Company's factor purchases trade accounts receivables on a non-recourse basis and without any further obligations. Trade accounts receivables balances sold are removed from the consolidated balance sheets and cash received are reflected as cash provided by operating activities in the consolidated statements of cash flow. The difference between the fair value of the Company's trade receivables and the proceeds received is recorded as interest expense in the Company's condensed consolidated statements of operations, and for the three and nine months ended September 28, 2019, the Company's recognized factoring related interest expense was approximately $0.1 million and $0.5 million,
respectively. The gross amount of trade accounts receivables sold during the three and nine months ended September 28, 2019, totaled approximately $17.2 million and $62.8 million, respectively. The Company did not enter into any factoring arrangements during the three and nine months ended September 29, 2018.